Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution...
Reexamination Certificate
2011-03-15
2011-03-15
Leith, Patricia (Department: 1655)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
C424S776000, C514S023000
Reexamination Certificate
active
07906153
ABSTRACT:
Compositions with synergistic anti-inflammatory effects in inflammatory diseases resulting from activation and consequent degranulation of mast cells and followed by secretion of inflammatory biochemicals from the activated mast cells, the compositions containing one or more of a flavone or flavonoid glycoside a heavily sulfated, non-bovine proteoglycan, an unrefined olive kernel extract that increases absorption of these compositions in various routes of administration, a hexosamine sulfate such as D-glucosamine sulfate, S-adenosylmethionine, a histamine-1 receptor antagonist, a histamine-3 receptor agonist, an antagonist of the actions of CRH, a long-chain unsaturated fatty acid, a phospholipid, Krill oil, a polyamine, glutiramer acetate and interferon. Certain of the present compositions are useful in protecting against the neuropathological components of multiple sclerosis and similar inflammatory neurological diseases.
REFERENCES:
patent: 4265823 (1981-05-01), Nobile
patent: 4447443 (1984-05-01), Goldenberg
patent: 4767778 (1988-08-01), Arrang et al.
patent: 5223257 (1993-06-01), Arora
patent: 5250529 (1993-10-01), Theoharides
patent: 5260335 (1993-11-01), Wagner et al.
patent: 5434183 (1995-07-01), Larsson-Backstrom
patent: 5560917 (1996-10-01), Cohen et al.
patent: 5587363 (1996-12-01), Henderson
patent: 5648355 (1997-07-01), Theoharides
patent: 5661170 (1997-08-01), Chodosh
patent: 5747049 (1998-05-01), Tominaga
patent: 5795905 (1998-08-01), McCarthy et al.
patent: 5804594 (1998-09-01), Murad
patent: 5821259 (1998-10-01), Theoharides
patent: 5831259 (1998-11-01), Charra
patent: 5840715 (1998-11-01), Florio
patent: 5855884 (1999-01-01), Theoharides
patent: 5858371 (1999-01-01), Singh et al.
patent: 5876744 (1999-03-01), Della Valle et al.
patent: 5972999 (1999-10-01), Murad
patent: 5980865 (1999-11-01), Ahmed
patent: 5994357 (1999-11-01), Theoharides
patent: 6020305 (2000-02-01), Theoharides
patent: 6136795 (2000-10-01), Florio
patent: 6162787 (2000-12-01), Sorgente et al.
patent: 6211195 (2001-04-01), Webb et al.
patent: 6271213 (2001-08-01), Henderson et al.
patent: 6579544 (2003-06-01), Rosenberg et al.
patent: 6583123 (2003-06-01), Henderson et al.
patent: 6586448 (2003-07-01), DeNinno et al.
patent: 6624148 (2003-09-01), Theoharides
patent: 6635625 (2003-10-01), Theoharides
patent: 6641806 (2003-11-01), Theoharides
patent: 6645482 (2003-11-01), Theoharides
patent: 6689748 (2004-02-01), Theoharides
patent: 6765008 (2004-07-01), Chen
patent: 6911436 (2005-06-01), Brown et al.
patent: 6984667 (2006-01-01), Theoharides
patent: 7115278 (2006-10-01), Theoharides
patent: 2001/0000340 (2001-04-01), Chen et al.
patent: 2002/0009448 (2002-01-01), Weiner et al.
patent: 2002/0028779 (2002-03-01), High et al.
patent: 2002/0064568 (2002-05-01), Rose et al.
patent: 2002/0146393 (2002-10-01), Bell et al.
patent: 2004/0005355 (2004-01-01), Theoharides
patent: 2004/0039066 (2004-02-01), Crea
patent: 2004/0180106 (2004-09-01), Theoharides
patent: 2005/0220909 (2005-10-01), Theoharides
patent: 2005/0220912 (2005-10-01), Theoharides
patent: 2006/0013905 (2006-01-01), Tehoharides
patent: 2006/0210551 (2006-09-01), Lindsberg et al.
patent: 2007/0077317 (2007-04-01), Theoharides
patent: 2007/0141187 (2007-06-01), Theoharides
patent: 2008/0153761 (2008-06-01), Theoharides
patent: 2009/0148543 (2009-06-01), Theoharides
patent: 0426479 (1991-05-01), None
patent: 1157693 (2001-11-01), None
patent: 1157693 (2001-11-01), None
patent: 2105193 (1984-09-01), None
patent: 1290440 (1998-09-01), None
patent: 2006016531 (2006-01-01), None
patent: WO-89/05646 (1989-06-01), None
patent: WO-90/06104 (1990-06-01), None
patent: WO-93/09766 (1993-05-01), None
patent: WO-97/21434 (1997-06-01), None
patent: WO-98/33494 (1998-08-01), None
patent: WO-99/21434 (1999-05-01), None
patent: WO-00/78320 (2000-12-01), None
patent: WO-02/060393 (2002-08-01), None
Grant, A. Food; Fish Without the Fuss; Sunday Mirror, London, Sep. 3, 2000, p. 37 (pp. 1-5 of ProQuest print-out).
Dr. Duke; Phytochemical and Ethnobotanical Databeses; Chemicals in:Olea europaea subsp. europaea(OLEACEAE)—Olive; URL <http://www.ars-grin.gov/cgi-bin/duke/farmacy2.pl> accessed Jun. 1, 2006, pp. 1-5.
Ronca et al. Anti-Inflammatory Activity of Chondroitin Sulfate; Osteoarthritis and Cartilage (1998), 6, Supplement A, pp. 14-21.
Starbuck, J. Elderberry 7 Cat's Claw Wisely Harnessing the Power of Herbs for Immune-Boosting and More; Better Nutrition, Atlanta, GA, Sep. 1998, vol. 60, Issue 9, p. 54, 4 pages (pp. 1-5 from ProQuest).
Chandrasekar et al. : Tissue Specific Regulation of Transforming Growth Factor Beta by Omega-3 Lipid-Rich Krill Oil in Autoimmune Murine Lupus; Nutrition Research, vol. 16, No. 3, pp. 489-503.
Olive Seed Oil: Osumex; URL <www.osumex.com/olive.php> accessed on the WWW on Jun. 27, 2006 pp. 1-2.
Quercetin: The Mens Health Shop; URL<www.ishop.co.uk/ishop/451/shopscr130.html> accessed on the WWW on Jun. 27, 2006, one page.
Scott et al.; Nonsteroidal Antiinflammatory Agents in the Management of Canine Pruritis; Journal of American Animal Hospital Association; Jul./Aug. 1988, vol. 24 pp. 425-428.
Queen Creek Olive Mill- a Guide to Olive Oil; URL<www.queencreekolivemill.com/aboutoil.jsp> accessed Dec. 7, 2007, pp. 1-2.
OilsbyNatureInc. Online: Olive Oil Pomace; URL<www.oilsbynature.com/products/olive-oil-pomace-refined.htm>, accessed Dec. 7, 2007, pp. 1-2.
The Olive Oil Source: Definitions, URL<www.oliveoilsource.com/definitions.htm>, accessed Dec. 7, 2007, pp. 1-6.
Agro Tropical Spain: Wholesale Olive Oil; URL<www.agrotropical.andes.com/olive—oil/differentiating—spanish—olive—oil—wholesale.htm> accessed Dec. 7, 2007, pp. 1-5.
Boushey, R. et al., “Adrenal Cortical Carcinoma,” Curr. Treatment Op. Oncol., 2: 355-364 (2001).
Cefali, E.A. et al., “Aspirin reduces cutaneous flushing after administration of an optimized extended-release niacin formulations,” Int. J. Clin. Pharm. Ther., vol. 45: 78-88 (2007).
Chines, A. et al., “Systemic Mastocytosis Presenting as Osteoporosis: A Clinical and Histomorphometric Study,” J. Clin. Endocrinol. And Metab., vol. 72(1): 140-144 (1991).
Database WPI: 2001-358435 - XP002221703, “Compositions comprising hyaluronic acid and flavonoids,” (2001).
Devlin, Thomas (ed): Textbook of Biochemistry with Clinical Correlations, 2nd Edition: Ch. 8.5-8.6, 345-351 (1982).
Dimitriadou, V. et al., Histochemical and Ultrastructural Characteristics of Rat Brain Perivascular Mast Cells Stimulated With Compound 48/80 and Carbachol, Neuroscience, vol. 39(1): 209-224 (1990).
Dunn, R.T. et al., “Low-Dose Aspirin and Ibuprofen Reduce The Cutaneous Reactions Following Niacin Administration,” Am. J. Thera., 2: 478-480 (1995).
Dvorak, A.M. et al., “Human Gut Mucosal Mast Cell: Ultrastructural Observations and Anatomic Variation In Mast Cell-Nerve Associations in vivo, ”vol. 98: 158-168 (1992).
Gupta, E. et al., “Lovastatin and Extended-Release Niacin Combination Product: The First Drug Combination for the Management of Hyperlipidemia,” Heart Disease, vol. 4: 124-137 (2002).
Hendriks, J. et al., “Flavonoids Influence Monocytic GTPase Activity and Are Protective in Experimental Allergic Encephalitis,” J. Exp. Med., vol. 200(12): 1667-1672 (Dec. 20, 2004).
International Search Report and Written Opinion, International Patent Application No. PCT/US08/86059, mailed Jan. 26, 2009 (2 pages).
International Search Report issued for PCT/US02/00476, dated Dec. 16, 2002 (6 pages).
International Search Report issued for PCT/US95/01392, dated May 31, 1995 (4 pages).
Irani, A-M, et al., “Mast Cell Changes in Scleroderma,” Arth. and Rheuma., vol. 35(8): 933- 939 (Aug. 1992).
Kimata, M. et al., “Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells,” Clin. and Exper. Allergy, vol. 30, 501-508 (2000).
Koblenzer, C.S. “Neur
Leith Patricia
Theta Biomedical Consulting & Development Co., Inc.
Wilmer Cutler Pickering Hale & Dorr LLP.
LandOfFree
Anti-inflammatory compositions for treating multiple sclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-inflammatory compositions for treating multiple sclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-inflammatory compositions for treating multiple sclerosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2745534